MedPath

A study to assess the change of bone mineral in response to increased dietary calcium intake in children.

Not Applicable
Registration Number
CTRI/2023/05/052693
Lead Sponsor
The New York Academy of Sciences.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Healthy children between 6 to 10 years old. Vitamin D 25OHD ( > 20ng/mL). Non-anaemic Hb >11.5.0 g/dL. Z score >- 2SD. Not taking any food supplements/fortified drinks. Not planning to move out during the study duration.

Exclusion Criteria

Age: <6 and >10 years Severe anemia (Hb <8g/dl) Severely malnourished children with weight for height Z score < -3SD Any food allergy or food intolerance Any metabolic, gastrointestinal kidney or chronic diseases such as diabetes, hepatitis, hypertension, cancer, or cardiovascular diseases (according to the participant’s statement) Continuous/long-term use of medication during the whole study Consumption of mineral and vitamin supplements within 2 weeks before the start of the study Blood transfusion, blood donation or significant blood loss (accident, surgery) over the past 4 months Earlier participation in any clinical study within the last 30 days A participant who cannot be expected to comply with the study protocol (e.g., not available on certain study appointments) Likely to move out of the study area within the period of the study intervention. Difficulties with blood samplinG.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the change in urinary calcium as a reliable biomarker for calcium status/bone mineralization in children in response to increased dietary calcium intake. <br/ ><br>Timepoint: Weeks 1,4,8,12
Secondary Outcome Measures
NameTimeMethod
ILTimepoint: NI
© Copyright 2025. All Rights Reserved by MedPath